Is the prophylaxis of patent ductus arteriosus useful in extremely premature infants?
This study was aimed to verify the efficacy and safety of ibuprofen prophylaxis of patent ductus arteriosus in very preterm infants, in order to select infants receiving higher benefits from this intervention. Two hundred neonates with gestational age (GA) < or = 28 weeks receiving ibuprof...
Saved in:
| Main Authors: | Iliana Bersani, Maria Pia De Carolis, Serafina Lacerenza, Gabriella De Rosa, Francesca Paola Fusco, Francesco Cota, Costantino Romagnoli |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Hacettepe University Institute of Child Health
2011-04-01
|
| Series: | The Turkish Journal of Pediatrics |
| Online Access: | https://turkjpediatr.org/article/view/1749 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Management of patent ductus arteriosus in premature infants.
by: A. Obolonskyi, et al.
Published: (2019-06-01) -
Management of Patent Ductus Arteriosus in Premature Babies: The Art and The Sciences
by: Jieh-Neng Wang
Published: (2014-08-01) -
Postoperative chylous ascites: increased scrotal volume as "alarm bell"
by: Maria Pia De Carolis, et al.
Published: (2010-12-01) -
Severe sepsis in a premature neonate: protein C replacement therapy
by: Maria Pia De Carolis, et al.
Published: (2008-08-01) -
Therapeutic strategy of patent ductus arteriosus in extremely preterm infants
by: Bai-Horng Su, et al.
Published: (2020-04-01)